Werewolf Therapeutics
(NASDAQ) HOWL
Werewolf Therapeutics Financials at a Glance
Market Cap
$37.90M
Revenue (TTM)
$0.00
Net Income (TTM)
$60.82M
EPS (TTM)
$-1.33
P/E Ratio
-0.48
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$0.80
Volume
2,370
Open
$0.77
Price
$0.80
Volume
2,370
Open
$0.77
Previous Close
$0.80
Daily Range
$0.77 - $0.83
52-Week Range
$0.53 - $2.38
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$0.80
Volume
2,370
Open
$0.77
Previous Close
$0.80
Daily Range
$0.77 - $0.83
52-Week Range
$0.53 - $2.38
HOWL News
HOWL: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Werewolf Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
39
CEO
Dan Hicklin, PhD
Website
www.werewolftx.comHeadquarters
Watertown, MA 02138, US
HOWL Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-124%
Return on Capital
-2%
Return on Assets
-88%
Earnings Yield
-2.08%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$37.90M
Shares Outstanding
48.54M
Volume
2.37K
Short Interest
0.00%
Avg. Volume
468.90K
Financials (TTM)
Gross Profit
$1.63M
Operating Income
$60.68M
EBITDA
$59.04M
Operating Cash Flow
$60.29M
Capital Expenditure
$0.00
Free Cash Flow
$60.29M
Cash & ST Invst.
$57.95M
Total Debt
$9.44M
Werewolf Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$400.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$37.90M
N/A
Market Cap/Employee
$823.92K
N/A
Employees
46
N/A
Net Income
$8.38M
+58.9%
EBITDA
$11.04M
+40.9%
Quarterly Fundamentals
Net Cash
$48.52M
-34.4%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$15.37M
-56.7%
Short Term Debt
$1.75M
+12.5%
Return on Assets
-87.64%
N/A
Return on Invested Capital
-1.82%
N/A
Free Cash Flow
$11.02M
+23.3%
Operating Cash Flow
$11.02M
+22.6%